» Articles » PMID: 18631387

Non-protein Coding RNA Biomarkers and Differential Expression in Cancers: a Review

Overview
Publisher Biomed Central
Specialty Oncology
Date 2008 Jul 18
PMID 18631387
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In these years a huge number of human transcripts has been found that do not code for proteins, named non-protein coding RNAs. In most cases, small (miRNAs, snoRNAs) and long RNAs (antisense RNA, dsRNA, and long RNA species) have many roles, functioning as regulators of other mRNAs, at transcriptional and post-transcriptional level, and controlling protein ubiquitination and degradation. Various species of npcRNAs have been found differentially expressed in different types of cancer. This review discusses the published data and new results on the expression of a subset of npcRNAs.

Conclusion: These results underscore the complexity of the RNA world and provide further evidence on the involvement of functional RNAs in cancer cell growth control.

Citing Articles

Biological and clinical relevance of correlated expression levels of coding and long noncoding RNAs in HPV16 positive cervical cancers.

Ghosh A, Sinha A, Ghosh A, Roy S, Mallick S, Kumar V Hum Genomics. 2024; 18(1):91.

PMID: 39210444 PMC: 11360852. DOI: 10.1186/s40246-024-00660-2.


lncRNA MIR503HG Targets miR-191-5p/PLCD1 Axis and Negatively Modulates Apoptosis, Extracellular Matrix Disruption, and Inflammation in Abdominal Aortic Aneurysm.

Tian Y, Li X, Bai C, Yang Z, Zhang L, Luo J Mediators Inflamm. 2023; 2023:4003618.

PMID: 37228901 PMC: 10205412. DOI: 10.1155/2023/4003618.


Multi-Omics Approaches in Colorectal Cancer Screening and Diagnosis, Recent Updates and Future Perspectives.

Ullah I, Yang L, Yin F, Sun Y, Li X, Li J Cancers (Basel). 2022; 14(22).

PMID: 36428637 PMC: 9688479. DOI: 10.3390/cancers14225545.


DNA Methylation Regulates a Set of Long Non-Coding RNAs Compromising Hepatic Identity during Hepatocarcinogenesis.

Recalde M, Garate-Rascon M, Herranz J, Elizalde M, Azkona M, Unfried J Cancers (Basel). 2022; 14(9).

PMID: 35565178 PMC: 9102946. DOI: 10.3390/cancers14092048.


Current Achievements and Applications of Transcriptomics in Personalized Cancer Medicine.

Supplitt S, Karpinski P, Sasiadek M, Laczmanska I Int J Mol Sci. 2021; 22(3).

PMID: 33572595 PMC: 7866970. DOI: 10.3390/ijms22031422.


References
1.
Kluiver J, Poppema S, de Jong D, Blokzijl T, Harms G, Jacobs S . BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol. 2005; 207(2):243-9. DOI: 10.1002/path.1825. View

2.
Goodrich J, Kugel J . Non-coding-RNA regulators of RNA polymerase II transcription. Nat Rev Mol Cell Biol. 2006; 7(8):612-6. DOI: 10.1038/nrm1946. View

3.
Ji P, Diederichs S, Wang W, Boing S, Metzger R, Schneider P . MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene. 2003; 22(39):8031-41. DOI: 10.1038/sj.onc.1206928. View

4.
Aggarwal B, Sethi G, Ahn K, Sandur S, Pandey M, Kunnumakkara A . Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution. Ann N Y Acad Sci. 2007; 1091:151-69. DOI: 10.1196/annals.1378.063. View

5.
Murad J, de Souza L, De Lucca F . PKR activation by a non-coding RNA expressed in lymphocytes of mice bearing B16 melanoma. Blood Cells Mol Dis. 2006; 37(2):128-33. DOI: 10.1016/j.bcmd.2006.05.004. View